NCT06243211

Brief Summary

This is a single-blinded (with outcome assessors blinded to treatment allocation), 12-month pilot study to evaluate of the safety, feasibility, and preliminary efficacy of dorsal myelotomy and expansive duraplasty performed either without or with autologous nerve graft implantation after acute traumatic spinal cord injury. Ten participants will be allocated to receive either DMED (n=5) or DMED + ANGI (n=5) based on a block design. Participants and assessors will be blinded to group allocation. Excess sural nerve samples will be collected for banking/analysis (may include proteomic, culturing, genomic, cellular analysis).

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for not_applicable

Timeline
8mo left

Started Apr 2024

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress76%
Apr 2024Dec 2026

First Submitted

Initial submission to the registry

January 28, 2024

Completed
9 days until next milestone

First Posted

Study publicly available on registry

February 6, 2024

Completed
2 months until next milestone

Study Start

First participant enrolled

April 19, 2024

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Last Updated

December 10, 2025

Status Verified

December 1, 2025

Enrollment Period

2.7 years

First QC Date

January 28, 2024

Last Update Submit

December 3, 2025

Conditions

Keywords

DecompressionDorsalDuraplastyMyelotomyNerve Graft

Outcome Measures

Primary Outcomes (2)

  • SCIM- Spinal Cord Independence Measures vIII

    The SCIM has been developed to address three specific areas of function in patients with spinal cord injuries (SCI). It looks at self-care (feeding, grooming, bathing, and dressing), respiration and sphincter management, and a patient's mobility abilities (bed and transfers and indoors/outdoors).

    Day 84 through day 364

  • AIS (2019)

    American Spinal Injury Association International standards for neurological classification of spinal cord injury Assessment

    Screening through day 364

Study Arms (2)

DMED

ACTIVE COMPARATOR

Dorsal myelotomy and expansive duraplasty (DMED) only.

Procedure: DMED

DMED + ANGI

ACTIVE COMPARATOR

Dorsal myelotomy and expansive duraplasty (DMED) and supplemental autologous nerve graft implantation (ANGI).

Procedure: DMEDProcedure: ANGI

Interventions

DMEDPROCEDURE

Decompression of spinal cord with stabilization - posterior approach.

Also known as: Spinal Cord decompression and stabilization
DMEDDMED + ANGI
ANGIPROCEDURE

Implantation of nerve tissue following decompression ans stabilization.

Also known as: Autologous Nerve Graft Implantation
DMED + ANGI

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age: = 18 years and = 80 years
  • Written informed consent by patient or legal authorized representative
  • No other life-threatening injury
  • No evidence of sepsis
  • Acute cervical or thoracic SCI with ASIA Impairment Scale grade A or B on admission
  • Non-penetrating SCI at neurologic level from C2 to C8 or T1 to T12
  • The ability to undergo surgical intervention including study procedures through a posterior approach within 48 hours of injury

You may not qualify if:

  • Unconsciousness or other mental impairment that prevents neurological assessment within the first 48 hours
  • Acute SCI with ASIA Impairment Scale grade C, D or E
  • Spinal cord decompression and spinal stabilization can be safely performed through an anterior-only approach (i.e. posterior approach is not required)
  • Currently involved in another non-observational SCI research study or receiving another investigational drug
  • Other illness (including mental disorder) that could preclude accurate medical and neurological evaluation (at discretion of the principal investigator)
  • Unable to commit to the follow-up schedule
  • A recent history of regular substance abuse (illicit drugs, alcohol), which in the opinion of the investigator would interfere with the subject's participation in the study
  • Any condition likely to result in the patient's death within the next 12 months
  • Prisoner
  • Pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Kentucky - Chandler Medical Center

Lexington, Kentucky, 40536, United States

RECRUITING

Related Publications (1)

  • Al-Sharshahi Z, Wilcox JT, Darabi H, Arora H, Quintero JE, Gerhardt GA, van Horne CG, Farhadi F. Design and protocol for the decompression-plus trial: a phase 1 clinical study of dorsal myelotomy and expansive duroplasty with or without autologous nerve grafting in acute traumatic spinal cord injury. Neurosurg Rev. 2025 Jul 8;48(1):547. doi: 10.1007/s10143-025-03701-z.

MeSH Terms

Conditions

Spinal Cord Injuries

Interventions

Laminectomy

Condition Hierarchy (Ancestors)

Spinal Cord DiseasesCentral Nervous System DiseasesNervous System DiseasesTrauma, Nervous SystemWounds and Injuries

Intervention Hierarchy (Ancestors)

Orthopedic ProceduresTherapeuticsDecompression, SurgicalSurgical Procedures, OperativeNeurosurgical Procedures

Study Officials

  • Francis H Farhadi, MD, PhD

    University of Kentucky Neurosurgery

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Francis H Farhadi, MD, PhD

CONTACT

Harshit Arora, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
Single-blinded (with outcome assessors blinded to treatment allocation)
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: This is a single-blinded (with outcome assessors blinded to treatment allocation), 12-month pilot study to evaluate of the safety, feasibility, and preliminary efficacy of dorsal myelotomy and expansive duraplasty performed either without or with autologous nerve graft implantation after acute traumatic spinal cord injury. Ten participants will be allocated to receive either DMED (n=5) or DMED + ANGI (n=5) based on a block design. Participants and assessors will be blinded to group allocation. Excess sural nerve samples will be collected for banking/analysis (may include proteomic, culturing, genomic, cellular analysis).
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Associate Professor, Neurosurgery

Study Record Dates

First Submitted

January 28, 2024

First Posted

February 6, 2024

Study Start

April 19, 2024

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

December 31, 2026

Last Updated

December 10, 2025

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will not share

Locations